Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

2022; Elsevier BV; Volume: 399; Issue: 10335 Linguagem: Inglês

10.1016/s0140-6736(22)00327-0

ISSN

1474-547X

Autores

Cristina Menni, Ana M. Valdes, Lorenzo Polidori, Michela Antonelli, Satya Penamakuri, Ana Nogal, Panayiotis Louca, Anna May, Jane C. Figueiredo, Christina Hu, Erika Molteni, Liane S. Canas, Marc F. Österdahl, Marc Modat, Carole H. Sudre, Ben Fox, Alexander Hammers, Jonathan Wolf, Joan Capdevila Pujol, Andrew T. Chan, Sean P. David, Claire J. Steves, Sébastien Ourselin, Tim D. Spector,

Tópico(s)

Long-Term Effects of COVID-19

Resumo

The SARS-CoV-2 variant of concern, omicron, appears to be less severe than delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, and symptom duration among the vaccinated population.

Referência(s)